Risk Scoring Model for Endometrial Cancer

Assessment of Risk Scoring Model for Prediction of Endometrial Cancer Among Symptomatic Postmenopausal Women(a Prospective Cohort Study).

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03298100

Acronym

Cohort

Enrollment

100

Registered

2017-09-29

Start date

2017-09-26

Completion date

2019-03-20

Last updated

2018-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oncology

Brief summary

A prospective cohort study to assess RHEA ( recurrent vaginal bleeding, hypertension, endometrial thickness and age) scoring model for prediction of endometrial carcinoma

Interventions

OTHERScoring model

Determining risk factors an calculating the risk score, recurrent vaginal bleeding 3, hypertension 2, age and endometrial thickness 1 for each

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

\- All postmenopausalwomen with vaginal bleeding and endometrial thickness more than 4 mm

Exclusion criteria

* all patients with vaginal bleeding arising from cervical or vaginal or vulval disease or due to hormonal replacement therapy (scheduled bleeding).

Design outcomes

Primary

Measure	Time frame	Description
Specificity and sensitivity of RHEA scoring mdel	One year	Positive and negative productive values, specificity and sensitivity of RHEA scoring model

Secondary

Measure	Time frame	Description
Variables to increase specificity and sensitivity of the score model	One year	Obesity, diabetes mellitus and family history

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026